In addition to oral talactoferrin, Agennix has several earlier-stage programs in its pipeline that may offer potential for further development and provide partnering opportunities.

-       Topical Talactoferrin
-       RGB-286638 Multi Targeted Kinase Inhibitor
-       Satraplatin